Design and Synthesis of Metabolically stable Tricyclic-SpiroLactams inhibitors of Mycobacterium tuberculosis type-II NADH dehydrogenase: Structure–Activity and Structure–Property Relationship Studies
Design and Synthesis of Metabolically stable Tricyclic-SpiroLactams inhibitors of Mycobacterium tuberculosis type-II NADH dehydrogenase: Structure–Activity and Structure–Property Relationship Studies
18/05/2026
Faion, L. et al.; Chemrxiv, 2026, https://doi.org/10.26434/chemrxiv.15002798/v1
